ArticleJournal of thoracic disease2019

Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.

Yasuhiro Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.